ProMIS Neurosciences Inc. Common Shares (ON) (PMN) is a publicly traded Healthcare sector company. As of October 30, 2026, PMN trades at $3.83 with a market cap of $99.27M and a P/E ratio of -0.41. PMN moved -64.03% today. Year to date, PMN is +49.73%; over the trailing twelve months it is +6.54%. Its 52-week range spans $6.27 to $39.75. Analyst consensus is strong buy with an average price target of $43.00. Rallies surfaces PMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for PMN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $3.83 |
| Market Cap | $99.27M |
| P/E Ratio | -0.41 |
| EPS | $-22.61 |
| Dividend Yield | 0.00% |
| 52-Week High | $39.75 |
| 52-Week Low | $6.27 |
| Volume | 1.02M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-39.72M |
| Gross Margin | 0.00% |
5 analysts cover PMN: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $43.00.